HIMS stock plunged by 18% after the FDA news that resolved a shortage of weight-loss drugs like Ozempic and Wegovy, which previously allowed Hims & Hers to sell compounded alternatives. Compounded …
https://moneymorning.com/2025/02/21/why-is-hims-stock-down-so-much-should-you-buy/

